Curaleaf Curaleaf Holdings, Inc. (TSX:CURA) (OTCQX:CURLF) will report its financial and operating results for the third quarter that ended Sept. 30, 2024 after market close on Nov. 6, 2024.
The cannabis giant said it would host a conference call and audio webcast on the same day at 5:00 pm Eastern Time.
Curaleaf reported its second-quarter financials in August, revealing revenue of $342 million, up by 2% from the same quarter of the previous year. The company also reported a net loss of $48.9 million for the quarter, marking a per-share loss of $0.06.
Nevertheless, the company has continued to actively expand its global and domestic footprint. Internationally, revenue surged by 78% for the second quarter, driven by robust performance in the UK and Germany.
The company has also recognized the potential of Poland’s medical marijuana market, as its subsidiary, Curaleaf International, expanded in the European country this year via the acquisition of Can4Med, a pharmaceutical wholesaler specializing in cannabinoid medication.
Read Also: Europe Is Turning Cash Flow Positive, ‘We’ll See What Happens In The U.S.,’ Says Curaleaf’s Boris Jordan
- Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.
Curaleaf named its executive chairman Boris Jordan as the new CEO in August, after Matt Darin announced his retirement plans.
Jordan is one of the keynote speakers at the upcoming Benzinga event in Illinois. Come, join us at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.
Curaleaf's shares traded 0.67% lower at $2.96 per share at the time of writing on Monday morning.